Sponsor:
Tela Bio Inc
Code:
NCT04779918
Conditions
Hernia, Ventral
Hernia, Inguinal
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Interventions
OviTex Reinforced Tissue Matrix
Brief summary:
Conditions
Hernia, Ventral
Hernia, Inguinal
Study ID
NCT04779918
Start date
Apr 29, 2021
Status verified date
Apr, 2026
Completion date
Dec 30, 2029
Anticipated
Primary completion date
Mar 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Enrollment
160 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
other: OviTex Reinforced Tissue Matrix
Interventions
OviTex Reinforced Tissue Matrix
Primary outcome measure
Central contacts
Locations
University of South Alabama
Recruiting
Mobile, Alabama, United States, 36617
Contacts
Principal Investigator:
Daniel McMahon, MD
University of Louisville
Recruiting
Louisville, Kentucky, United States, 40202
Contacts
Principal Investigator:
Farid Kehdy, MD
Munson Healthcare
Recruiting
Traverse City, Michigan, United States, 49684
Contacts
Kelly VanSchouwen
kelly@researchtex.comPrincipal Investigator:
Joel Strehl, DO
Sponsor
Tela Bio Inc
Last update posted
May 5, 2026
Last verified
Apr, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Tela Bio Inc on 2026-05-05.